Vimizim Injection, Solution, Concentrate
Product Images NDC 68135-100

1 FDA label image from Biomarin Pharmaceutical Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vimizim (NDC 68135-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomarin Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Vimizim 5mg/5ml (Vimizim 1)

Vimizim 5mg/5ml (Vimizim 1)
Label for Vimizim (elosulfase alfa) Injection, 5 mg per 5 mL (1 mg/mL) concentrate, indicated for intravenous infusion. The label states the product must be diluted prior to use and is Rx Only. The labeler is BioMarin Pharmaceutical Inc., with NDC 68135-100-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.